Close Menu

JP Morgan Healthcare Conference

CEO Jay Flatley preannounced fourth-quarter revenues of $512 million and also unveiled the HiSeq X Five System, the HiSeq 3000 and 4000 Systems, and the NextSeq 550 System, an NGS system enabled for array scanning. 

NEW YORK (GenomeWeb News) – Sequenom officials on Thursday elaborated on the firm's plans to develop a lower-cost noninvasive prenatal test for fetal aneuploidy.

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference concluded here Thursday with presentations from several life science tools and diagnostic firms.

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference continued here Wednesday with presentations from several life science tools and diagnostic firms.

NEW YORK (GenomeWeb News) – Laboratory Corporation of America is planning on expanding its portfolio of genomics-based diagnostics, CEO David King said this week at the JP Morgan Healthcare Conference.

NEW YORK (GenomeWeb News) - Illumina President and CEO Jay Flatley today introduced two new sequencing platforms, new technological advances in the firm’s optics and flow cells, and reported preliminary fourth quarter figures for the firm.

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference kicked off here Monday with several life science tools and diagnostic firms making presentations to investors and other attendees.

This story has been updated from a previous version to clarify Exact Sciences' FDA submission timeline.

This article has been updated from a previous version to clarify the company's reimbursement goals for 2013.

This article was originally published Jan. 8.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.